{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:58:35Z","timestamp":1770998315650,"version":"3.50.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1097\/inf.0b013e31829e6b9f","type":"journal-article","created":{"date-parts":[[2013,6,19]],"date-time":"2013-06-19T12:22:12Z","timestamp":1371644532000},"page":"63-69","source":"Crossref","is-referenced-by-count":33,"title":["Long-term Effectiveness of Combination Antiretroviral Therapy and Prevalence of HIV Drug Resistance in HIV-1\u2013infected Children and Adolescents in Rwanda"],"prefix":"10.1097","volume":"33","author":[{"given":"Philippe R.","family":"Mutwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly R.","family":"Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Rusine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narcisse","family":"Muganga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Tuyishimire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Schuurman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joep M. A.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibyl P. M.","family":"Geelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-15-20210202","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1001\/jama.298.16.1888","article-title":"Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.","volume":"298","author":"Bolton-Moore","year":"2007","journal-title":"JAMA"},{"key":"R2-15-20210202","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/QAI.0b013e3181b9869f","article-title":"Pediatric AIDS Clinical Trials Group219219C Team. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.","volume":"53","author":"Brady","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R3-15-20210202","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa011157","article-title":"Pediatric AIDS Clinical Trials Group Protocol 219 Team. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.","volume":"345","author":"Gortmaker","year":"2001","journal-title":"N Engl J Med"},{"key":"R4-15-20210202","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1086\/521167","article-title":"Collaborative HIV Paediatric Study (CHIPS); National Study of HIV in Pregnancy and Childhood (NSHPC). Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care.","volume":"45","author":"Judd","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R5-15-20210202","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/01.inf.0000091282.70253.5f","article-title":"Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.","volume":"22","author":"Sanchez","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R9-15-20210202","first-page":"730","article-title":"International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration. Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration.","volume":"99","author":"Davies","year":"2009","journal-title":"S Afr Med J"},{"key":"R10-15-20210202","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1097\/00002030-200409240-00006","article-title":"Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote dIvoire.","volume":"18","author":"Fassinou","year":"2004","journal-title":"AIDS"},{"key":"R11-15-20210202","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1097\/QAD.0b013e328010943b","article-title":"ANRS 12441278 Programme Enfants Yopougon. Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens.","volume":"20","author":"Rouet","year":"2006","journal-title":"AIDS"},{"key":"R12-15-20210202","first-page":"126","article-title":"Virologic and immunologic outcomes in HIV-infected Cambodian children after 18 months of highly active antiretroviral therapy (HAART).","volume":"41","author":"Sophan","year":"2010","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"R13-15-20210202","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/515596","article-title":"Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.","volume":"178","author":"Abrams","year":"1998","journal-title":"J Infect Dis"},{"key":"R14-15-20210202","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/QAI.0b013e31814278c0","article-title":"Academic Alliance for AIDS Care and Prevention in Africa. Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy.","volume":"46","author":"Kamya","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R15-15-20210202","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.332.7551.1183","article-title":"Collaborative HIV Paediatric Study Steering Committee. Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort study.","volume":"332","author":"Menson","year":"2006","journal-title":"BMJ"},{"key":"R16-15-20210202","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/11587300-000000000-00000","article-title":"Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges.","volume":"13","author":"Phelps","year":"2011","journal-title":"Paediatr Drugs"},{"key":"R17-15-20210202","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/00002030-200409240-00007","article-title":"Collaborative HIV Paediatric Study (CHIPS) Steering Committee. Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study.","volume":"18","author":"Walker","year":"2004","journal-title":"AIDS"},{"key":"R18-15-20210202","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/QAD.0b013e3283492180","article-title":"HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine.","volume":"25","author":"Hunt","year":"2011","journal-title":"AIDS"},{"key":"R22-15-20210202","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/01.aids.0000131310.52526.c7","article-title":"The prevalence of antiretroviral drug resistance in the United States.","volume":"18","author":"Richman","year":"2004","journal-title":"AIDS"},{"key":"R23-15-20210202","first-page":"434375","article-title":"Long-term outcome of an HIV-treatment programme in Rural Africa: viral suppression despite early mortality.","volume":"2011","author":"Barth","year":"2011","journal-title":"AIDS Res Treat"},{"key":"R25-15-20210202","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1097\/QAD.0b013e328318f148","article-title":"Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda.","volume":"22","author":"Kiboneka","year":"2008","journal-title":"AIDS"},{"key":"R26-15-20210202","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1473-3099(08)70180-4","article-title":"Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa.","volume":"8","author":"Sutcliffe","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"R27-15-20210202","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2334-11-54","article-title":"Weight and height z-scores improve after initiating ART among HIV-infected children in rural Zambia: a cohort study.","volume":"11","author":"Sutcliffe","year":"2011","journal-title":"BMC Infect Dis"},{"key":"R28-15-20210202","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2431-10-56","article-title":"Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study.","volume":"10","author":"Musoke","year":"2010","journal-title":"BMC Pediatr"},{"key":"R29-15-20210202","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/INF.0b013e318194eea6","article-title":"Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy.","volume":"28","author":"Puthanakit","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R30-15-20210202","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11904-996-0005-2","article-title":"Thymic function in HIV infection.","volume":"2","author":"Hazra","year":"2005","journal-title":"Curr HIVAIDS Rep"},{"key":"R31-15-20210202","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1570162043484898","article-title":"The thymus during HIV disease: role in pathogenesis and in immune recovery.","volume":"2","author":"Ye","year":"2004","journal-title":"Curr HIV Res"},{"key":"R33-15-20210202","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/QAI.0b013e3182060610","article-title":"International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration. Virologic failure and second-line antiretroviral therapy in children in South Africa-the IeDEA Southern Africa collaboration.","volume":"56","author":"Davies","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R34-15-20210202","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1471-2334-12-197","article-title":"Predictors of treatment failure and time to detection and switching in HIV-infected Ethiopian children receiving first line anti-retroviral therapy.","volume":"12","author":"Bacha","year":"2012","journal-title":"BMC Infect Dis"},{"key":"R35-15-20210202","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/QAI.0b013e3181cf4882","article-title":"Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study.","volume":"54","author":"Emmett","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R36-15-20210202","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/jac\/dkq234","article-title":"Drug resistance is widespread among children who receive long-term antiretroviral treatment at a rural Tanzanian hospital.","volume":"65","author":"Bratholm","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R37-15-20210202","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/01.inf.0000190413.88671.92","article-title":"Genotypic human immunodeficiency virus type 1 drug resistance in highly active antiretroviral therapy-treated children in Abidjan, Cote dIvoire.","volume":"24","author":"Chaix","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R38-15-20210202","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/jac\/dkp412","article-title":"Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali.","volume":"65","author":"Germanaud","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R39-15-20210202","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/jmv.20912","article-title":"Anti-retroviral drug resistance-associated mutations among non-subtype B HIV-1-infected Kenyan children with treatment failure.","volume":"79","author":"Lwembe","year":"2007","journal-title":"J Med Virol"},{"key":"R40-15-20210202","first-page":"92","article-title":"Drug resistance mutations in HIV-1.","volume":"11","author":"DAquila","year":"2003","journal-title":"Top HIV Med"},{"key":"R41-15-20210202","first-page":"266","article-title":"International AIDS Society-USA. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.","volume":"16","author":"Hirsch","year":"2008","journal-title":"Top HIV Med"},{"key":"R42-15-20210202","first-page":"69","article-title":"Genetic barriers to resistance and impact on clinical response.","volume":"7","author":"Luber","year":"2005","journal-title":"MedGenMed"},{"key":"R43-15-20210202","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/aid.2009.0164","article-title":"Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda.","volume":"26","author":"Towler","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R44-15-20210202","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/QAI.0b013e3181fbcbf7","article-title":"Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children.","volume":"56","author":"Ruel","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R45-15-20210202","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/00002030-200106150-00015","article-title":"Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.","volume":"15","author":"Bangsberg","year":"2001","journal-title":"AIDS"},{"key":"R46-15-20210202","doi-asserted-by":"crossref","first-page":"e10460","DOI":"10.1371\/journal.pone.0010460","article-title":"Early adherence to antiretroviral medication as a predictor of long-term HIV virological suppression: five-year follow up of an observational cohort.","volume":"5","author":"Ford","year":"2010","journal-title":"PLoS One"},{"key":"R47-15-20210202","doi-asserted-by":"crossref","first-page":"e41998","DOI":"10.1371\/journal.pone.0041998","article-title":"High risk of ART non-adherence and delay of ART initiation among HIV positive double orphans in Kigali, Rwanda.","volume":"7","author":"Kikuchi","year":"2012","journal-title":"PLoS One"},{"key":"R48-15-20210202","doi-asserted-by":"crossref","first-page":"e60073","DOI":"10.1371\/journal.pone.0060073","article-title":"Living situation affects adherence to combination antiretroviral therapy in HIV-infected adolescents in Rwanda: a qualitative study.","volume":"8","author":"Mutwa","year":"2013","journal-title":"PLoS One"},{"key":"R49-15-20210202","first-page":"1","article-title":"Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings.","volume":"5","author":"Scanlon","year":"2013","journal-title":"HIV AIDS (Auckl)"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0b013e31829e6b9f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:11:51Z","timestamp":1620954711000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201401000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31829e6b9f","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}